ARTICLE | Clinical News
Hyal Pharmaceuticals Corp. regulatory update
October 3, 1994 7:00 AM UTC
Hyal Pharmaceuticals Corp. (HYALF) The Mississauga, Ontario, company's HYAL-CT1101 received approval under Canada's Emergency Drug Release program to treat actinic keratosis in immune suppressed pati...